Mark J. Barbour

161 Cathedral Street
Glasgow, SCT G40RE, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines.

Protease-activated receptor 2 activation induces behavioural changes associated with depression-like behaviour through microglial-independent modulation of inflammatory cytokines.

Journal: Psychopharmacology

Published: August 17, 2021

Anti-CD52 antibody treatment in murine experimental autoimmune encephalomyelitis induces dynamic and differential modulation of innate immune cells in peripheral immune and central nervous systems.

Anti-CD52 antibody treatment in murine experimental autoimmune encephalomyelitis induces dynamic and differential modulation of innate immune cells in peripheral immune and central nervous systems.

Journal: Immunology

Published: August 05, 2021

Increased Levels of IL-16 in the Central Nervous System during Neuroinflammation Are Associated with Infiltrating Immune Cells and Resident Glial Cells.

Increased Levels of IL-16 in the Central Nervous System during Neuroinflammation Are Associated with Infiltrating Immune Cells and Resident Glial Cells.

Journal: Biology

Published: April 20, 2021

Role of IL-33/ST2 signaling pathway in systemic sclerosis and other fibrotic diseases.

Role of IL-33/ST2 signaling pathway in systemic sclerosis and other fibrotic diseases.

Journal: Clinical and experimental rheumatology

Published: December 20, 2018

Expression and Function of IL-33/ST2 Axis in the Central Nervous System Under Normal and Diseased Conditions.

Expression and Function of IL-33/ST2 Axis in the Central Nervous System Under Normal and Diseased Conditions.

Journal: Frontiers in immunology

Published: August 03, 2018

The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels.

The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels.

Journal: Journal of neuroimmunology

Published: October 04, 2017

Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.

Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.

Journal: Pharmacology research & perspectives

Published: September 26, 2017

MAP kinase phosphatase 2 deficient mice develop attenuated experimental autoimmune encephalomyelitis through regulating dendritic cells and T cells.

MAP kinase phosphatase 2 deficient mice develop attenuated experimental autoimmune encephalomyelitis through regulating dendritic cells and T cells.

Journal: Scientific reports

Published: June 28, 2016

Effect of sphingosine kinase modulators on interleukin-1β release, sphingosine 1-phosphate receptor 1 expression and experimental autoimmune encephalomyelitis.

Effect of sphingosine kinase modulators on interleukin-1β release, sphingosine 1-phosphate receptor 1 expression and experimental autoimmune encephalomyelitis.

Journal: British journal of pharmacology

Published: March 16, 2016

Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.

Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.

Journal: Molecular oncology

Published: February 25, 2015

IL-33 attenuates the development of experimental autoimmune uveitis.

IL-33 attenuates the development of experimental autoimmune uveitis.

Journal: European journal of immunology

Published: March 19, 2014

Emerging role of interleukin-33 in autoimmune diseases.

Emerging role of interleukin-33 in autoimmune diseases.

Journal: Immunology

Published: August 21, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026